SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Lucid Group, Inc. manufactures electric vehicles. It designs, develops, and builds energy storage systems for electric vehicles and supplies automakers with the battery pack system needed to power hybrid, plug-in, and electric vehicles. The company was founded in December 2007 and is headquartered in Newark, CA.

Lucid Group Inc

Lucid Group is trending as community members debate the impact of a recent reverse stock split and discuss the company's leadership. Some investors express confidence due to Saudi PIF backing and recent commercials, while others voice concerns about the company's financial performance and potential dilution. News of increased Gravity SUV production and a closed Uber investment are also circulating among investors.

Gyrodyne LLC engages in the management of a portfolio of medical office and industrial properties. Its properties include Flowerfield, Port Jefferson Professional Park, Courtland Medical Center, and Grove. The company was founded by Peter James Papadakos in 1946 and is headquartered in St. James, NY.

Gyrodyne LLC

GYRO is trending as traders focus on its low float, anticipating a potential breakout and significant upward price movement. The community is actively discussing entry points, key breakout levels, and potential price targets, with some comparing it to other low-float stocks that have experienced substantial gains. A recent land sale and a shareholder meeting are also contributing to the increased interest.

Abivax SA engages in the sale, research, distribution, and development of biopharmaceutical products. It offers commercial and development products of anti-viral compounds and human vaccines. The commercialized products include vaccines for typhoid fever, meningococcus, and leptospirosis. The products under development include vaccines for chronic hepatitis B, ebola, and dengue virus. The company was founded by Philippe Pouletty on December 4, 2003 and is headquartered in Paris, France.

Abivax - ADR

Abivax is trending due to takeover speculation fueled by a Betaville rumor mentioning a large American pharmaceutical company as a potential suitor. The community is discussing the validity of the rumor and comparing the stock's potential to previous significant runs in the biotech sector. Some investors hope for a buyout, while others prefer the company to remain independent for further growth.

The project is a derivative of Fartcoin. The Fartcoin deployer has deployed this token because the President at Bone Fide Wealth tweeted about "A client just called and asked me if there’s going to be a Fartcoin ETF this year." Since the Elon narrative is has been running this one has come to existence. The token is following different narratives like Fartcoin, SPX500 and other big memes following the Trump narrative.

Elon Trump Fart

ETF500.X is trending as the community rallies around the project, especially after recent rebrand updates. Despite some negative sentiment directed at its founder, Zack Morris, the community emphasizes its strength and commitment to the tokenized version of the S&P500 on the Solana blockchain.

GFL Environmental, Inc. engages in the business of transporting, managing, and recycling of solid and liquid waste and the provision of soil remediation services. It operates through the following segments: Solid Waste, Environmental Services, and Corporate. The Solid Waste segment includes hauling, landfill, transfers, and material recovery facilities. The Environmental Services segment provides liquid waste management and soil remediation services. The company was founded by Patrick Dovigi on December 19, 2007 and is headquartered in Vaughan, Canada.

GFL Environmental Inc. - Ordinary Shares (Sub Voting)

GFL is trending due to positive analyst ratings and raised price targets, with community members discussing the potential for a breakout. Recent reports highlight the company's growth strategy, M&A activity, and focus on balance sheet improvements. Discussions also mention GFL's position in the defensive waste management sector and its expansion into renewable energy projects.

Kodiak Sciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the research, development, and commercialization of therapeutics for retinal diseases. Its product pipeline includes KSI-301 for wet AMD, KSI-301 for diabetic eye disease, KSI-501 for DME and uveitis, KSI-201 for resistant wet AMD, and KSI-401 for dry AMD. The company was founded by Stephen A. Charles and Victor Perlroth in 2009 and is headquartered in Palo Alto, CA.

Kodiak Sciences Inc

Kodiak Sciences is trending as community members speculate on the potential impact of upcoming ophthalmology health conferences and data readouts, particularly regarding their pipeline including Tarcocimab and KSI-101. Bullish investors are encouraged by recent gains and are hoping for positive news, while others discuss potential buyouts and short squeezes. The stock's history of volatility and long-term prospects remain a key point of discussion.

Avalanche is a high throughput smart contract blockchain platform. Validators secure the network through a proof-of-stake consensus protocol. It is said to be fast, low cost, and environmental friendly.

Avalanche

Avalanche is trending as the community anticipates a breakout, fueled by discussions around potential catalysts like real-world asset tokenization and increased network activity. Some traders are pointing to bullish chart setups and comparing AVAX to other layer-1 solutions, while others express frustration with its price action relative to the broader crypto market. Community members are actively debating entry and exit strategies amidst speculation of an upcoming altcoin season.

Pineapple Financial, Inc. is a Canadian based mortgage technology and brokerage company, which engages in the mortgage brokerage services and technology solutions to Canadian mortgage agents, brokers, sub-brokers, brokerages, and consumers. The company also provides back-office services, together with pre-underwriting support services. The company was founded by Shubha Dasgupta, Kendall Marin, and Charles Andrew Green on October 16, 2015 and is headquartered in North York, Canada.

Pineapple Financial Inc

Pineapple Financial ($PAPL) is trending amid discussions around its digital asset treasury strategy involving Injective (INJ) tokens, sparking volatility and talk of potential short squeezes. Community members are actively debating the company's recent private placement and its impact on the stock's future, with bulls eyeing continued upside while bears cite potential dilution risks. The stock's low float and high borrow costs are also contributing to the heightened interest and speculative trading.

SSgA Active Trust - Technology Select Sector SPDR ETF

Technology Select Sector SPDR Fund

The Technology Select Sector SPDR Fund ($XLK) is trending as investors assess the impact of potential tariffs and a possible rotation out of tech stocks. Community discussions revolve around key support levels, bearish technical formations like head-and-shoulders patterns, and whether the recent tech selloff presents a buying opportunity. Some analysts suggest strong corporate earnings and demand for AI could support the sector, while others highlight risks associated with a slowing economy and trade tensions.

BrokeCoin is a meme-meets-utility cryptocurrency project operating under the ethos of Transparency, Community, and Respect. Formally registered as an LLC in Wyoming, USA, BrokeCoin is building an expansive ecosystem that combines light-hearted spirit of meme culture with real-world crypto utilities—spanning gaming, staking, NFTs, web services, and an e-commerce platform. Brokecoin believes in developing useful and interesting meme-inspired utilities to both service the crypto industry, and generate value for holders.

Brokecoin

Brokecoin is trending as the community rallies around upcoming staking features and airdrop details. The community is actively discussing its consistent growth and dedication to long-term development, emphasizing its unique ecosystem. With a focus on community engagement and utility, Brokecoin aims to stand out in the meme coin space.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Cocrystal Pharma (NASDAQ:COCP) Stock Rating Reaffirmed by HC Wainwright

HC Wainwright restated their buy rating on shares of Cocrystal Pharma (NASDAQ:COCP - Free Report) in a report published on Thursday morning, Benzinga reports. They currently have a $10.00 target...

Cocrystal Pharma, Inc. (NASDAQ:COCP) to Post Q1 2025 Earnings of ($0.49) Per Share, HC Wainwright Forecasts

Cocrystal Pharma, Inc. (NASDAQ:COCP - Free Report) - Investment analysts at HC Wainwright issued their Q1 2025 earnings per share estimates for shares of Cocrystal Pharma in a research report...

Cocrystal Pharma GAAP EPS of -$1.87

COCP Stock Earnings: Cocrystal Pharma Beats EPS for Q4 2023

InvestorPlace - Stock Market News, Stock Advice & Trading Tips
COCP stock results show that Cocrystal Pharma beat analyst estimates for earnings per share the fourth quarter of 2023.
The post COCP...

Recap: Cocrystal Pharma Q4 Earnings

Cocrystal Pharma sees cash runway beyond next 12 months

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

Cocrystal Pharma reports 2023 EPS ($1.87), consensus ($2.09)

Cocrystal Pharma Reports 2023 Financial Results and Provides Updates on its Antiviral Drug-Development Programs

FDA feedback following the Company's submission of a Pre-IND briefing package improves clarity on regulatory requirements for Phase 2b influenza A clinical trial with oral CC-42344, a broad-spectrum...

Cocrystal Pharma Receives Pre-IND Responses from the FDA on Oral CC-42344 for Treating Influenza A

Feedback provides greater clarity on regulatory requirements for planned Phase 2b trial BOTHELL, Wash., March 19, 2024 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) ( Cocrystal or...

Cocrystal Pharma Discusses Antiviral Therapeutics' Clinical Development and 2024 Value Catalysts in New CEO Video Interview on Planet MicroCap

LOS ANGELES, CA / ACCESSWIRE / March 5, 2024 / Planet MicroCap today published a new Video Interview with Jim Martin, Co-CEO and CFO, from Cocrystal Pharma, Inc. (NASDAQ:COCP), a clinical-stage...

Cocrystal Pharma, Inc. is a clinical-stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication process of influenza viruses, coronaviruses (including SARS-CoV-2), noroviruses and hepatitis C viruses. Cocrystal employs unique structure-based technologies to create first- and best-in-class antiviral drugs. The company was founded in 2008 and is headquartered in Bothell, WA.

COCP
Cocrystal Pharma Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest COCP News

COCP Cocrystal Pharma Inc